David J Beech Selected Research

David J Beech Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 10/2013
6	Insulin Resistance 01/2020 - 08/2011
5	Atherosclerosis 01/2020 - 10/2003
4	Hyperplasia 01/2021 - 02/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 07/2018 - 03/2015
3	Kidney Neoplasms (Kidney Cancer) 01/2022 - 03/2015
3	Inflammation (Inflammations) 04/2012 - 07/2010
3	Rheumatoid Arthritis 06/2010 - 11/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 03/2017
2	Thrombosis (Thrombus) 10/2013 - 04/2012
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Obesity 01/2021
1	Ischemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 10/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2020
1	Weight Gain 01/2019
1	Synovial Sarcoma (Synovioma) 12/2017
1	Visceral Pain 10/2016
1	Pancreatitis 10/2013
1	Myocardial Infarction 10/2013
1	Hypertrophy 10/2013
1	Hypoxia (Hypoxemia) 09/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2010
1	Poisoning 02/2010
1	Congenital Hyperinsulinism 07/2009
1	Joint Diseases (Joint Disease) 01/2008
1	Vascular Diseases (Vascular Disease) 10/2005
1	Vascular System Injuries 08/2005

Drug/Important Bio-Agent (IBA)

8	Ion Channels (Ion Channel)IBA 01/2019 - 11/2007
6	englerin AIBA 01/2022 - 01/2017
5	CalciumIBA 03/2015 - 06/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2015
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021 - 08/2011
3	Biological ProductsIBA 09/2020 - 01/2018
3	Superoxides (Superoxide)IBA 01/2020 - 06/2013
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 06/2013
3	Insulin (Novolin)FDA Link 03/2017 - 07/2009
2	Insulin ReceptorIBA 01/2021 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2012
2	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2019
2	Cytotoxins (Cytolysins)IBA 07/2018 - 01/2018
2	SesquiterpenesIBA 12/2017 - 03/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013 - 09/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 08/2011
1	Nonsense Codon (Nonsense Mutation)IBA 01/2022
1	antibiotic G 418IBA 01/2022
1	TRPC6 Cation ChannelIBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	AC1903IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	LipidsIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	AdiponectinIBA 01/2019
1	tonantzitloloneIBA 01/2018
1	DiterpenesIBA 01/2018
1	EstersIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 03/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2017
1	Adenosine Triphosphatases (ATPase)IBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 03/2015
1	Matrix Metalloproteinases (MMPs)IBA 10/2013
1	Protein Isoforms (Isoforms)IBA 06/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012
1	InterleukinsIBA 09/2012
1	CytokinesIBA 09/2012
1	Stromal Interaction MoleculesIBA 04/2012
1	Small Interfering RNA (siRNA)IBA 08/2011
1	AntioxidantsIBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 06/2011
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 02/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2010
1	PregnenoloneIBA 06/2010
1	Hyaluronic Acid (Hyaluronan)IBA 06/2010
1	MetalsIBA 02/2010
1	KATP ChannelsIBA 07/2009
1	Adenosine Triphosphate (ATP)IBA 07/2009
1	ThioredoxinsIBA 01/2008
1	Potassium Channels (Potassium Channel)IBA 10/2005
1	Vasoconstrictor AgentsIBA 08/2005
1	Endothelin-1 (Endothelin 1)IBA 10/2003
1	CholesterolIBA 10/2003

Therapy/Procedure

2	Therapeutics 10/2016 - 03/2015
1	Drug Therapy (Chemotherapy) 10/2016